{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and posted_year = 2001 sorted by posted_date descending", "rows": [["FDA-2001-N-0018-0001", "FDA", "FDA-2001-N-0018", "Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementation of the Common Technical Document; Notice of Public Meeting", "Notice", "General Notice", "2001-12-31T05:00:00Z", 2001, 12, null, null, "2025-02-10T16:52:56Z", "01-32123", 0, 0, "09000064804b5107"], ["FDA-1978-N-0018-0441", "FDA", "FDA-1978-N-0018", "Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Partial Stay; Final Rule", "Notice", "Notice of Stay of Action", "2001-12-31T05:00:00Z", 2001, 12, "2001-12-31T05:00:00Z", "2002-04-02T04:59:59Z", "2019-07-25T19:32:43Z", "01-32086", 0, 0, "090000648055a801"], ["FDA-1993-D-0022-0001", "FDA", "FDA-1993-D-0022", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-12-31T05:00:00Z", 2001, 12, "2001-12-27T05:00:00Z", null, "2008-05-16T23:23:01Z", null, 0, 0, "09000064804face9"], ["FDA-2001-N-0015-0001", "FDA", "FDA-2001-N-0015", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; Customer/Partner Service Surveys", "Notice", "30 Day Proposed Information Collection", "2001-12-31T05:00:00Z", 2001, 12, "2001-12-20T05:00:00Z", "2002-01-23T04:59:59Z", "2025-01-17T16:28:25Z", "01-31335", 0, 0, "09000064804b4d73"], ["FDA-2001-D-0223-0001", "FDA", "FDA-2001-D-0223", "FDA", "Notice", "N-Notice", "2001-12-28T05:00:00Z", 2001, 12, "2001-12-28T05:00:00Z", "2002-03-21T04:59:59Z", "2008-04-25T02:28:02Z", null, 0, 0, "09000064804e5374"], ["FDA-2001-P-0155-0001", "FDA", "FDA-2001-P-0155", "FDA/DDM to Arnall, Golden Gregory", "Other", "ACK-Acknowledgement Letter", "2001-12-27T05:00:00Z", 2001, 12, null, null, "2008-04-25T02:27:48Z", null, 0, 0, "09000064804df043"], ["FDA-2001-P-0053-0001", "FDA", "FDA-2001-P-0053", "Acknowledgment Letter from FDA DMB to Wilmer, Cutler & Pickering", "Other", "Acknowledgement Letter/Receipt", "2001-12-27T05:00:00Z", 2001, 12, null, null, "2024-09-23T22:37:14Z", null, 0, 0, "09000064804b7e38"], ["FDA-2000-D-1403-0001", "FDA", "FDA-2000-D-1403", "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies", "Notice", "Guidance", "2001-12-21T05:00:00Z", 2001, 12, "2021-10-01T04:00:00Z", "2002-12-12T04:59:59Z", "2024-11-07T21:53:19Z", null, 1, 0, "09000064804f0f7f"], ["FDA-2001-N-0172-0002", "FDA", "FDA-2001-N-0172", "FDA", "Notice", "N-Notice", "2001-12-17T05:00:00Z", 2001, 12, "2001-12-17T05:00:00Z", "2002-01-15T04:59:59Z", "2008-04-25T02:27:22Z", null, 0, 0, "09000064804e0ae7"], ["FDA-2001-P-0452-0001", "FDA", "FDA-2001-P-0452", "Approval Letter from FDA CDER to AA1 International", "Other", "Approval", "2001-12-17T05:00:00Z", 2001, 12, "2021-01-28T05:00:00Z", null, "2021-02-01T17:19:08Z", null, 0, 0, "0900006484a0af87"], ["FDA-2001-P-0191-0001", "FDA", "FDA-2001-P-0191", "FDA/DDM to Hogan & Hartson, LLP", "Other", "ACK-Acknowledgement Letter", "2001-12-11T05:00:00Z", 2001, 12, null, null, "2008-04-25T02:25:58Z", null, 0, 0, "09000064804e2665"], ["FDA-2001-P-0215-0002", "FDA", "FDA-2001-P-0215", "Acknowledgment Letter from FDA DMB to Omega Laboratories, Ltd.", "Other", "ACK-Acknowledgement Letter", "2001-12-07T05:00:00Z", 2001, 12, null, null, "2024-08-23T13:49:30Z", null, 0, 0, "09000064804e488d"], ["FDA-2001-N-0230-0002", "FDA", "FDA-2001-N-0230", "FDA", "Notice", "NCR-Notice of Correction", "2001-12-07T05:00:00Z", 2001, 12, null, null, "2008-04-25T02:38:50Z", null, 0, 0, "09000064804e5d77"], ["FDA-2001-D-0040-0001", "FDA", "FDA-2001-D-0040", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-29T05:00:00Z", 2001, 11, "2001-11-29T05:00:00Z", "2002-01-29T04:59:59Z", "2008-04-25T01:57:07Z", null, 0, 0, "09000064804b6d71"], ["FDA-2001-P-0086-0002", "FDA", "FDA-2001-P-0086", "FDA/OC  to Washington Legal Foundation", "Other", "LET-Letter", "2001-11-27T05:00:00Z", 2001, 11, null, null, "2008-04-25T02:23:19Z", null, 0, 0, "09000064804b8543"], ["FDA-2001-N-0070-0002", "FDA", "FDA-2001-N-0070", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; FDA Recall Regulations", "Notice", "30 Day Proposed Information Collection", "2001-11-27T05:00:00Z", 2001, 11, "2001-08-17T04:00:00Z", "2001-09-18T03:59:59Z", "2024-12-09T19:21:59Z", "01-20842", 0, 0, "09000064804b825f"], ["FDA-2001-D-0032-0004", "FDA", "FDA-2001-D-0032", "FDA", "Notice", "NEC-Notice of Extension", "2001-11-21T05:00:00Z", 2001, 11, "2001-11-21T05:00:00Z", "2001-11-27T04:59:59Z", "2008-04-25T01:57:06Z", null, 0, 0, "09000064804b6347"], ["FDA-2001-D-0219-0002", "FDA", "FDA-2001-D-0219", "Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability", "Notice", "NAD-Notice of Availability of Data", "2001-11-20T05:00:00Z", 2001, 11, "2001-11-19T05:00:00Z", "2002-02-20T04:59:59Z", "2010-05-10T16:34:55Z", null, 0, 0, "09000064804e4e02"], ["FDA-1999-D-1301-0001", "FDA", "FDA-1999-D-1301", "Guidance for Industry: Information Request & Discipline Review Letters Under the Prescription Drug User Fee Act", "Notice", "Guidance", "2001-11-20T05:00:00Z", 2001, 11, "2001-11-20T05:00:00Z", null, "2025-06-17T21:52:51Z", null, 1, 0, "09000064804da900"], ["FDA-2001-N-0230-0001", "FDA", "FDA-2001-N-0230", "FDA", "Notice", "NM-Notice of Meeting", "2001-11-19T05:00:00Z", 2001, 11, "2001-11-19T05:00:00Z", "2002-01-26T04:59:59Z", "2008-04-25T02:38:50Z", null, 0, 0, "09000064804e5c39"], ["FDA-1978-N-0018-0440", "FDA", "FDA-1978-N-0018", "Memorandum of Meeting Between FDA/OCC and Cosmetic, Toiletry and Fragrance Association", "Other", "Memorandum", "2001-11-19T05:00:00Z", 2001, 11, null, null, "2019-08-07T12:11:46Z", null, 0, 0, "090000648055a7fe"], ["FDA-1999-N-0053-0004", "FDA", "FDA-1999-N-0053", "FDA", "Notice", "NFR-Notice of Final Rule", "2001-11-16T05:00:00Z", 2001, 11, null, null, "2008-04-25T00:00:45Z", null, 0, 0, "09000064804a6196"], ["FDA-1999-N-0083-0001", "FDA", "FDA-1999-N-0083", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-15T05:00:00Z", 2001, 11, "2001-11-15T05:00:00Z", "2002-03-14T04:59:59Z", "2008-04-25T00:00:59Z", null, 0, 0, "09000064804a6982"], ["FDA-2000-D-0196-0001", "FDA", "FDA-2000-D-0196", "Guidance for Industry: Fumonisin Levels in Human Foods and Animal Feeds; Availability", "Notice", "Notice of Availability", "2001-11-14T05:00:00Z", 2001, 11, "2001-11-09T05:00:00Z", "2002-11-10T04:59:59Z", "2018-10-10T18:41:38Z", null, 0, 0, "09000064804d4563"], ["FDA-1980-N-0074-0075", "FDA", "FDA-1980-N-0074", "FDA/ORA to Colgate-Palmolive Company", "Other", "PDN-Petition Denial", "2001-11-14T05:00:00Z", 2001, 11, null, null, "2008-05-30T22:52:47Z", null, 0, 0, "09000064805bb4db"], ["FDA-2001-D-0137-0002", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb03"], ["FDA-2001-D-0137-0007", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb0b"], ["FDA-2001-N-0176-0001", "FDA", "FDA-2001-N-0176", "FDA", "Notice", "N-Notice", "2001-11-06T05:00:00Z", 2001, 11, null, null, "2008-04-25T02:27:33Z", null, 0, 0, "09000064804e1102"], ["FDA-2001-N-0176-0002", "FDA", "FDA-2001-N-0176", "FDA", "Notice", "N-Notice", "2001-11-06T05:00:00Z", 2001, 11, null, null, "2008-04-25T02:27:34Z", null, 0, 0, "09000064804e133a"], ["FDA-2001-D-0137-0001", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddaef"], ["FDA-2001-N-0074-0002", "FDA", "FDA-2001-N-0074", "Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction", "Notice", "Correction", "2001-11-06T05:00:00Z", 2001, 11, null, null, "2025-01-29T14:22:16Z", "01-27520", 0, 0, "09000064804b831d"], ["FDA-2001-D-0137-0006", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb0a"], ["FDA-2001-D-0137-0009", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb0d"], ["FDA-2001-D-0137-0008", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb0c"], ["FDA-2001-N-0074-0003", "FDA", "FDA-2001-N-0074", "Schering Corp. et al.; Withdrawal of Approval of 51 New Drug Applications and 25 Abbreviated New Drug Applications; Correction", "Notice", "Correction", "2001-11-06T05:00:00Z", 2001, 11, null, null, "2025-01-29T14:37:32Z", "01-27520", 0, 0, "09000064804b831e"], ["FDA-2001-D-0137-0003", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb05"], ["FDA-2001-D-0137-0005", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb09"], ["FDA-2001-D-0137-0004", "FDA", "FDA-2001-D-0137", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-06T05:00:00Z", 2001, 11, "2001-11-06T05:00:00Z", "2002-02-05T04:59:59Z", "2008-04-25T02:25:55Z", null, 0, 0, "09000064804ddb08"], ["FDA-2001-D-0219-0001", "FDA", "FDA-2001-D-0219", "Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting", "Notice", "NM-Notice of Meeting", "2001-11-05T05:00:00Z", 2001, 11, null, null, "2010-05-10T16:33:19Z", null, 0, 0, "09000064804e4d7b"], ["FDA-2001-N-0016-0001", "FDA", "FDA-2001-N-0016", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report", "Notice", "30 Day Proposed Information Collection", "2001-11-05T05:00:00Z", 2001, 11, "2001-11-05T05:00:00Z", "2001-12-06T04:59:59Z", "2024-12-17T02:00:53Z", "01-27641", 0, 0, "09000064804b4ea8"], ["FDA-2001-N-0171-0001", "FDA", "FDA-2001-N-0171", "Agency Information Collection Activities; Announcement of OMB Approval; Third-Party Review Under FDAMA", "Notice", "Notice of Approval", "2001-11-05T05:00:00Z", 2001, 11, null, null, "2024-12-16T17:04:30Z", "01-27642", 0, 0, "09000064804e0921"], ["FDA-2000-D-0027-0001", "FDA", "FDA-2000-D-0027", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-11-05T05:00:00Z", 2001, 11, null, null, "2008-04-25T01:01:00Z", null, 0, 0, "09000064804aeaf2"], ["FDA-2018-D-4115-0013", "FDA", "FDA-2018-D-4115", "The Mammography Quality Standards Act Final Regulations: Preparing For MQSA Inspections; Final Guidance for Industry and FDA", "Other", "Guidance", "2001-11-04T05:00:00Z", 2001, 11, "2001-11-04T05:00:00Z", null, "2024-11-06T23:36:50Z", null, 1, 0, "0900006484644a3f"], ["FDA-2001-P-0239-0005", "FDA", "FDA-2001-P-0239", "Letter from FDA CFSAN to Krislov & Associates, LTD.", "Other", "Letter(s)", "2001-10-31T05:00:00Z", 2001, 10, "2020-07-06T04:00:00Z", null, "2024-09-09T17:22:16Z", null, 0, 0, "09000064804e6814"], ["FDA-2001-P-0239-0004", "FDA", "FDA-2001-P-0239", "Letter from FDA CFSAN to Center for Food Safety", "Other", "Letter(s)", "2001-10-31T05:00:00Z", 2001, 10, "2020-07-06T04:00:00Z", null, "2024-09-09T17:22:06Z", null, 0, 0, "09000064804e6812"], ["FDA-1998-N-0050-0002", "FDA", "FDA-1998-N-0050", "Annual Comprehensive List of Guidance Documents at the Food and Drug Administration", "Notice", "General Notice", "2001-10-29T05:00:00Z", 2001, 10, "2001-10-24T04:00:00Z", null, "2015-04-11T02:07:31Z", null, 0, 0, "090000648056e813"], ["FDA-2001-N-0174-0001", "FDA", "FDA-2001-N-0174", "Electronic Interchange Standard for Digital ECG and Similar Data; Public Meeting", "Notice", "Meeting", "2001-10-29T05:00:00Z", 2001, 10, null, null, "2025-02-06T02:00:57Z", "01-26821", 0, 0, "09000064804e0d65"], ["FDA-2001-N-0201-0001", "FDA", "FDA-2001-N-0201", "Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements", "Notice", "60 Day Proposed Information Collection", "2001-10-29T05:00:00Z", 2001, 10, null, null, "2025-02-04T17:06:58Z", "01-26885", 0, 0, "09000064804e35f6"], ["FDA-1999-F-0120-0003", "FDA", "FDA-1999-F-0120", "Food Additives Permitted for Direct Addition to Food for Human Consumption; Change in Specifications for Gum or Wood Rosin Derivatives in Chewing Gum Base; Correction", "Notice", "Correction", "2001-10-29T00:00:00Z", 2001, 10, null, null, "2025-05-02T18:20:56Z", "01-26708", 0, 0, "09000064804ae961"], ["FDA-2001-N-0199-0001", "FDA", "FDA-2001-N-0199", "Agency Information Collection Activities; Announcement of OMB Approval; Premarket Notification 510(k) Submissions", "Notice", "Notice of Approval", "2001-10-26T04:00:00Z", 2001, 10, null, null, "2024-12-10T16:05:25Z", "01-26573", 0, 0, "09000064804e3357"], ["FDA-2001-D-0094-0002", "FDA", "FDA-2001-D-0094", "FDA", "Notice", "N-Notice", "2001-10-23T04:00:00Z", 2001, 10, "2001-10-23T04:00:00Z", "2001-11-24T04:59:59Z", "2008-04-25T02:23:58Z", null, 0, 0, "09000064804b90d5"], ["FDA-2001-N-0104-0001", "FDA", "FDA-2001-N-0104", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Fast Track Drug Development Programs-Designation, Development, and Application Review", "Notice", "60 Day Proposed Information Collection", "2001-10-23T04:00:00Z", 2001, 10, "2001-10-23T04:00:00Z", "2001-12-25T04:59:59Z", "2025-02-03T20:03:20Z", "01-26575", 0, 0, "09000064804bae60"], ["FDA-1980-N-0074-0074", "FDA", "FDA-1980-N-0074", "FDA", "Notice", "N-Notice", "2001-10-22T04:00:00Z", 2001, 10, "2001-10-22T04:00:00Z", "2002-01-15T04:59:59Z", "2008-05-30T22:53:09Z", null, 0, 0, "09000064805bb4da"], ["FDA-2001-N-0170-0001", "FDA", "FDA-2001-N-0170", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Device Labeling Regulations", "Notice", "30 Day Proposed Information Collection", "2001-10-19T04:00:00Z", 2001, 10, "2001-10-16T04:00:00Z", "2001-11-16T04:59:59Z", "2024-12-19T19:57:40Z", "01-25943", 0, 0, "09000064804e07d0"], ["FDA-2001-N-0566-0001", "FDA", "FDA-2001-N-0566", "Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Investigational Use", "Notice", "60 Day Proposed Information Collection", "2001-10-19T04:00:00Z", 2001, 10, "2001-10-16T04:00:00Z", "2001-12-18T04:59:59Z", "2025-02-03T18:49:59Z", "01-25918", 0, 0, "090000648050b0cb"], ["FDA-1998-D-0037-0001", "FDA", "FDA-1998-D-0037", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2002-10-06T03:59:59Z", "2008-05-16T21:18:13Z", null, 0, 0, "0900006480565bc6"], ["FDA-2000-D-0100-0002", "FDA", "FDA-2000-D-0100", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2002-10-06T03:59:59Z", "2008-04-25T01:47:25Z", null, 0, 0, "09000064804c217b"], ["FDA-2000-P-0102-0004", "FDA", "FDA-2000-P-0102", "FDA", "Notice", "NEC-Notice of Extension", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2001-11-20T04:59:59Z", "2008-04-25T01:47:38Z", null, 0, 0, "09000064804c22da"], ["FDA-2000-P-0133-0004", "FDA", "FDA-2000-P-0133", "FDA", "Notice", "NEC-Notice of Extension", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2001-11-20T04:59:59Z", "2008-04-25T01:16:05Z", null, 0, 0, "09000064804cfd51"], ["FDA-1998-D-0037-0002", "FDA", "FDA-1998-D-0037", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2002-10-06T03:59:59Z", "2008-05-16T21:18:13Z", null, 0, 0, "0900006480565c35"], ["FDA-2001-N-0068-0001", "FDA", "FDA-2001-N-0068", "Agency Information Collection Activities; Announcement of OMB Approval; Good Laboratory Practices (GLP) Regulations for Nonclinical Laboratory Studies", "Notice", "Notice of Approval", "2001-10-12T04:00:00Z", 2001, 10, null, null, "2025-02-11T16:56:25Z", "01-25659", 0, 0, "09000064804b81dc"], ["FDA-2001-N-0226-0002", "FDA", "FDA-2001-N-0226", "Agency Information Collection Activities; Submission for OMB Review; Comment Request; Reports of Corrections and Removals", "Notice", "30 Day Proposed Information Collection", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-12T04:00:00Z", "2001-11-14T04:59:59Z", "2025-01-15T20:59:09Z", "01-25660", 0, 0, "09000064804e57a8"], ["FDA-2001-N-0072-0001", "FDA", "FDA-2001-N-0072", "Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practice Regulations for Type A Medicated Articles", "Notice", "Notice of Approval", "2001-10-12T04:00:00Z", 2001, 10, null, null, "2024-11-26T02:00:30Z", "01-25658", 0, 0, "09000064804b82d8"], ["FDA-2001-N-0105-0001", "FDA", "FDA-2001-N-0105", "Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Third-Party Premarket Submission Review and Quality System Inspections Under United States/European Community Mutual Recognition Agreement", "Notice", "60 Day Proposed Information Collection", "2001-10-12T04:00:00Z", 2001, 10, "2001-10-05T04:00:00Z", "2001-12-05T04:59:59Z", "2025-01-31T16:15:35Z", "01-24998", 0, 0, "09000064804bafb0"], ["FDA-2000-D-0068-0001", "FDA", "FDA-2000-D-0068", "FDA", "Notice", "NCR-Notice of Correction", "2001-10-11T04:00:00Z", 2001, 10, null, null, "2008-04-25T01:13:24Z", null, 0, 0, "09000064804afe17"], ["FDA-2001-N-0202-0002", "FDA", "FDA-2001-N-0202", "Workshop on Preclinical Testing for Endovascular Grafts", "Notice", "NM-Notice of Meeting", "2001-10-10T04:00:00Z", 2001, 10, null, null, "2009-01-07T16:52:55Z", null, 0, 0, "09000064804e3787"], ["FDA-2001-N-0202-0001", "FDA", "FDA-2001-N-0202", "Workshop on Preclinical Testing for Endovascular Grafts", "Notice", "NM-Notice of Meeting", "2001-10-10T04:00:00Z", 2001, 10, null, null, "2009-01-07T16:51:36Z", "01\u201316471", 0, 0, "09000064804e373f"], ["FDA-2001-N-0567-0001", "FDA", "FDA-2001-N-0567", "FDA", "Notice", "NH-Notice of Hearing", "2001-10-10T04:00:00Z", 2001, 10, null, null, "2008-04-25T02:39:30Z", null, 0, 0, "090000648050b0de"], ["FDA-1999-P-0059-0004", "FDA", "FDA-1999-P-0059", "FDA/DMB to Health Care Without Harm", "Other", "ACK-Acknowledgement Letter", "2001-10-05T04:00:00Z", 2001, 10, null, null, "2008-04-25T00:13:56Z", null, 0, 0, "09000064804a671c"], ["FDA-2001-N-0047-0002", "FDA", "FDA-2001-N-0047", "Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting; Cancellation", "Notice", "General Notice", "2001-10-02T04:00:00Z", 2001, 10, null, null, "2025-01-30T19:01:03Z", "01-24528", 0, 0, "09000064804b78ae"], ["FDA-1974-P-0001-0002", "FDA", "FDA-1974-P-0001", "Notice of Proposed Rule-Making re Vinyl Chloride as an Ingredient of Drug and Cosmetic Aerosol Products", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2001-10-02T04:00:00Z", 2001, 10, null, null, "2023-11-03T12:16:00Z", "74-19657", 0, 0, "090000648046a741"], ["FDA-2001-P-0005-0001", "FDA", "FDA-2001-P-0005", "Notice of Determination", "Notice", "N-Notice", "2001-10-01T04:00:00Z", 2001, 10, null, null, "2024-08-28T13:26:37Z", null, 0, 0, "09000064804b4014"], ["FDA-2001-N-0173-0001", "FDA", "FDA-2001-N-0173", "Agency Information Collection Activities; Proposed Collection; Comment Request; Rapid Response Surveys", "Notice", "60 Day Proposed Information Collection", "2001-10-01T04:00:00Z", 2001, 10, "2001-09-27T04:00:00Z", "2001-11-27T04:59:59Z", "2025-01-30T21:09:38Z", "01-24163", 0, 0, "09000064804e0bdd"], ["FDA-1998-D-0037-0003", "FDA", "FDA-1998-D-0037", "Content and Format for Geriatric Labeling", "Notice", "Guidance", "2001-10-01T04:00:00Z", 2001, 10, "2001-10-01T04:00:00Z", null, "2021-10-01T04:02:28Z", null, 0, 0, "0900006480565c32"], ["FDA-1974-P-0001-0001", "FDA", "FDA-1974-P-0001", "Notice of Proposed Rule-Making re: Vinyl Chloride as an Ingredient of Drug and Cosmetic Aerosol Products", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2001-10-01T04:00:00Z", 2001, 10, "2001-10-01T04:00:00Z", "1974-05-03T03:59:59Z", "2023-11-03T12:14:27Z", "74-9282", 0, 0, "090000648046a6ff"], ["FDA-2000-D-0002-0003", "FDA", "FDA-2000-D-0002", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-26T04:00:00Z", 2001, 9, null, null, "2008-04-25T01:13:52Z", null, 0, 0, "09000064804ae5c1"], ["FDA-2001-D-0164-0002", "FDA", "FDA-2001-D-0164", "Guidance", "Supporting & Related Material", "GDL-Guidance", "2001-09-26T04:00:00Z", 2001, 9, null, null, "2008-04-25T02:27:39Z", null, 0, 0, "09000064804dff9e"], ["FDA-2001-N-0172-0001", "FDA", "FDA-2001-N-0172", "FDA", "Notice", "N-Notice", "2001-09-26T04:00:00Z", 2001, 9, "2001-09-26T04:00:00Z", "2001-11-27T04:59:59Z", "2008-04-25T02:27:22Z", null, 0, 0, "09000064804e0a96"], ["FDA-2000-D-0002-0002", "FDA", "FDA-2000-D-0002", "Guidance", "Supporting & Related Material", "GDL-Guidance", "2001-09-26T04:00:00Z", 2001, 9, null, null, "2008-04-25T01:13:52Z", null, 0, 0, "09000064804ae5c0"], ["FDA-2001-D-0164-0001", "FDA", "FDA-2001-D-0164", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-26T04:00:00Z", 2001, 9, "2001-09-26T04:00:00Z", "2001-11-27T04:59:59Z", "2008-04-25T02:27:39Z", null, 0, 0, "09000064804dff39"], ["FDA-2001-N-0175-0001", "FDA", "FDA-2001-N-0175", "Meeting on 11/14-15/01", "Notice", "NM-Notice of Meeting", "2001-09-24T04:00:00Z", 2001, 9, "2001-09-24T04:00:00Z", "2001-12-18T04:59:59Z", "2008-04-25T02:27:52Z", null, 0, 0, "09000064804e0ed7"], ["FDA-2000-D-0031-0001", "FDA", "FDA-2000-D-0031", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-24T04:00:00Z", 2001, 9, "2001-09-24T04:00:00Z", "2001-12-25T04:59:59Z", "2008-04-25T01:12:34Z", null, 0, 0, "09000064804aeb8d"], ["FDA-2001-E-0151-0001", "FDA", "FDA-2001-E-0151", "Determination of Regulatory Review Period for Purposes of Patent Extension; Trileptal", "Notice", "General Notice", "2001-09-24T04:00:00Z", 2001, 9, "2001-09-24T04:00:00Z", "2001-11-24T04:59:59Z", "2025-09-15T16:10:58Z", null, 0, 0, "09000064804ddd1d"], ["FDA-2000-E-0239-0001", "FDA", "FDA-2000-E-0239", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; Synercid", "Notice", "General Notice", "2001-09-21T04:00:00Z", 2001, 9, "2001-09-21T04:00:00Z", "2002-03-21T04:59:59Z", "2025-07-09T16:09:54Z", null, 0, 0, "09000064804d59f6"], ["FDA-2001-E-0210-0001", "FDA", "FDA-2001-E-0210", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; Kaletra", "Notice", "General Notice", "2001-09-21T04:00:00Z", 2001, 9, "2001-09-21T04:00:00Z", "2002-03-21T04:59:59Z", "2025-10-01T18:13:42Z", null, 0, 0, "09000064804e41c2"], ["FDA-2001-F-0180-0001", "FDA", "FDA-2001-F-0180", "Secondary Direct Food Additives Permitted in Food for Human Consumption", "Notice", "Notice of Final Rule", "2001-09-21T04:00:00Z", 2001, 9, "2001-09-21T04:00:00Z", "2001-10-20T03:59:59Z", "2025-11-06T20:46:42Z", null, 0, 0, "09000064804e1878"], ["FDA-2001-E-0234-0001", "FDA", "FDA-2001-E-0234", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; Rescula", "Notice", "General Notice", "2001-09-21T04:00:00Z", 2001, 9, "2001-09-21T04:00:00Z", "2002-03-21T04:59:59Z", "2025-10-10T22:02:07Z", null, 0, 0, "09000064804e6296"], ["FDA-1996-P-0041-0001", "FDA", "FDA-1996-P-0041", "Memorandum from FDA, Dave Read (HFD-7) to FDA Dockets Management Branch (HFA-305)", "Other", "Memorandum", "2001-09-19T04:00:00Z", 2001, 9, null, null, "2024-06-20T14:22:26Z", null, 0, 0, "09000064804fc5e9"], ["FDA-1996-P-0025-0001", "FDA", "FDA-1996-P-0025", "FDA", "Notice", "Notice of Availability", "2001-09-18T04:00:00Z", 2001, 9, "2001-09-18T04:00:00Z", "2002-09-08T03:59:59Z", "2016-05-31T16:17:22Z", null, 0, 0, "09000064804faaa3"], ["FDA-1998-N-0087-0001", "FDA", "FDA-1998-N-0087", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-18T04:00:00Z", 2001, 9, "2001-09-18T04:00:00Z", "2002-09-08T03:59:59Z", "2008-05-16T21:37:51Z", null, 0, 0, "0900006480585263"], ["FDA-1994-P-0050-0002", "FDA", "FDA-1994-P-0050", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-18T04:00:00Z", 2001, 9, "2001-09-18T04:00:00Z", "2002-09-08T03:59:59Z", "2008-05-16T23:21:35Z", null, 0, 0, "09000064804ffa38"], ["FDA-1997-P-0017-0002", "FDA", "FDA-1997-P-0017", "Notice of Availability of Data re Small Entity Compliance Guide: \u201cFood Labeling: Safe Handling Statements, Labeling of Shell Eggs; Refrigeration of Shell Eggs Held for Retail Distribution;\u201d Availability", "Notice", "Notice of Data Availability", "2001-09-18T04:00:00Z", 2001, 9, "2001-09-18T04:00:00Z", "2002-09-08T03:59:59Z", "2015-05-12T15:29:10Z", null, 0, 0, "09000064805c9fc0"], ["FDA-2001-E-0027-0001", "FDA", "FDA-2001-E-0027", "FDA/CDER to the U. S. Patent & Trademark Office - Letter", "Other", "LET-Letter", "2001-09-12T04:00:00Z", 2001, 9, null, null, "2010-01-29T15:43:16Z", null, 0, 0, "09000064804b5c4f"], ["FDA-2001-N-0047-0001", "FDA", "FDA-2001-N-0047", "Preparation for ICH Meetings in Brussels, Belgium, Including Progress on Implementing of the Common Technical Document; Public Meeting", "Notice", "Meeting", "2001-09-12T04:00:00Z", 2001, 9, null, null, "2025-01-30T17:36:45Z", "01-22471", 0, 0, "09000064804b78a3"], ["FDA-2001-P-0216-0002", "FDA", "FDA-2001-P-0216", "FDA/CDER to Paul, Hastings, Janofsky & Walker LLP", "Other", "LET-Letter", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T02:38:56Z", null, 0, 0, "09000064804e4a25"], ["FDA-1999-P-0059-0003", "FDA", "FDA-1999-P-0059", "FDA/CDRH to Sanford J. Lewis", "Other", "PDN-Petition Denial", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T00:13:56Z", null, 0, 0, "09000064804a671a"], ["FDA-2001-P-0001-0002", "FDA", "FDA-2001-P-0001", "FDA/CDER to Mutual Pharmaceutical Company", "Other", "LET-Letter", "2001-09-11T04:00:00Z", 2001, 9, null, null, "2008-04-25T02:25:38Z", null, 0, 0, "09000064804b3acf"], ["FDA-2001-N-0133-0002", "FDA", "FDA-2001-N-0133", "Medical Devices; Exemption From Premarket Notification Requirements; Class I Devices", "Notice", "Correction", "2001-09-10T04:00:00Z", 2001, 9, null, null, "2025-02-11T15:27:21Z", "01-22577", 0, 0, "09000064804dda85"], ["FDA-2001-D-0061-0001", "FDA", "FDA-2001-D-0061", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-07T04:00:00Z", 2001, 9, "2001-09-07T04:00:00Z", "2001-11-06T04:59:59Z", "2008-04-25T01:57:12Z", null, 0, 0, "09000064804b80bb"], ["FDA-2001-D-0161-0001", "FDA", "FDA-2001-D-0161", "FDA", "Notice", "NAD-Notice of Availability of Data", "2001-09-06T04:00:00Z", 2001, 9, "2001-09-06T04:00:00Z", "2001-12-06T04:59:59Z", "2008-04-25T02:27:16Z", null, 0, 0, "09000064804dfb31"]], "truncated": false, "filtered_table_rows_count": 424, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "2001"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2001", "results": [{"value": "FDA", "label": "FDA", "count": 424, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?posted_year=2001", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2001", "results": [{"value": "Notice", "label": "Notice", "count": 192, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&document_type=Notice", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 163, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 65, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2001", "results": [{"value": 2001, "label": 2001, "count": 424, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_facet_date=last_modified"}], "next": "2001-09-06T04~3A00~3A00Z,FDA-2001-D-0161-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2001&_next=2001-09-06T04~3A00~3A00Z%2CFDA-2001-D-0161-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 810.6190040707588, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}